UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000948
Receipt number R000001138
Scientific Title Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer
Date of disclosure of the study information 2007/12/14
Last modified on 2008/12/17 22:16:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer

Acronym

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer

Scientific Title

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer

Scientific Title:Acronym

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer

Region

Japan


Condition

Condition

primary lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The feasibility of alpha-GalactosylCeramide-pulsed dendritic cell and natural killer T (NKT) cell immunotherapy in patients with advanced or recurrent lung cancer are examined. The immunological responses and anti-tumor effects are also investigated.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Safety

Key secondary outcomes

Immunological response and Clinical response


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

In patients with advanced or recurrent lung cancer, intra-venous injections of alpha-GalactosylCeramide pulsed DCs are performed at 1, 2, 7 and 8 weeks after the entry.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

patients had received no chemotherapy or radiotherapy
for at least 6 weeks before enrollment. patients with a histologic or cytological diagnosis of non-small cell lung cancer, life-expectancy is more than 6 months, Performance status 0-1, Normal bone marrow, liver and renal functions, NKT cells are detected at least 10 cells in 1 mL of peripheral blood

Key exclusion criteria

the presence of active infection; a history of hepatitis; a positive response for hepatitis B surface antigen, or human immunodeficiency virus (HIV), hepatitis C virus, or human T-lymphotrophic virus antibodies; evedence for other malignant diseases; serious cardiac disease, recieived concurrent corticosteroid therapy; pregnancy or lactation; been judged to be inappropriate to participate in this study by principle investigator or co-investigator

Target sample size

23


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takehiko Fujisawa

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Thoracic Surgery

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-226-2966

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shinichiro Motohashi

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Thoracic Surgery

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-226-2966

Homepage URL


Email



Sponsor or person

Institute

Department of Thoracic Surgery, Graduate School of Medicine, Chiba University

Institute

Department

Personal name



Funding Source

Organization

National Institute of Biomedical Innovation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 02 Month 05 Day

Date of IRB


Anticipated trial start date

2004 Year 02 Month 01 Day

Last follow-up date

2008 Year 05 Month 01 Day

Date of closure to data entry

2008 Year 08 Month 01 Day

Date trial data considered complete

2008 Year 10 Month 01 Day

Date analysis concluded

2008 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 12 Month 14 Day

Last modified on

2008 Year 12 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001138


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name